{"disease":{"id":"recessive-dystrophic-epidermolysis-bullosa","name":"recessive dystrophic epidermolysis bullosa"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04917887","title":"Long-Term Follow-up Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Krystal Biotech, Inc.","has_results":false},{"nct_id":"NCT04917874","title":"A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Krystal Biotech, Inc.","has_results":false},{"nct_id":"NCT04491604","title":"Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Krystal Biotech, Inc.","has_results":true},{"nct_id":"NCT03529877","title":"Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"RHEACELL GmbH & Co. KG","has_results":false},{"nct_id":"NCT03752905","title":"A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Phoenix Tissue Repair, Inc.","has_results":false},{"nct_id":"NCT05725018","title":"A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Abeona Therapeutics, Inc","has_results":false},{"nct_id":"NCT04227106","title":"Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Abeona Therapeutics, Inc","has_results":false},{"nct_id":"NCT03392909","title":"Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05944250","title":"A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT03012191","title":"Gentamicin for RDEB","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT04599881","title":"A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Phoenix Tissue Repair, Inc.","has_results":false},{"nct_id":"NCT02698735","title":"Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT04520022","title":"Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT04177498","title":"Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT02984085","title":"Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Holostem s.r.l.","has_results":false},{"nct_id":"NCT05143190","title":"Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Phoenix Tissue Repair, Inc.","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}